The company said that ZAMTO Cell is designed to target both CD19 and CD20, which could improve treatment efficacy.

Panacea Biotec Limited has announced that Manjula Upadhyay, Independent Director of the Company, has completed her second and ...

Panacea Biotec has announced that Sunil Anand, Associate Director - Finance & Corporate Affairs of the Company, designated as ...

This is why it is of great interest to develop methods that make it possible to experimentally characterize exosomes. Miltenyi Biotec's new MACSPlex Exosome kit, human enables the qualitative as well ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

We would like to inform you that as per the Scrutinizer''s Report, all the resolutions mentioned in the Postal Ballot notice dated February 14, 2025 have been passed by the shareholders with requisite ...

Involves transaction of at least 0.5% of the listed shares of a company. What was Onyx Biotec Ltd share price previously? Onyx Biotec Ltd share price was up by 4.41% from the previous closing ...

In this virtual symposium Miltenyi Biotec researchers and customers share their experiences along the CAR T cell and CAR NK cell development and manufacturing path. Scientists and clinicians will get ...